Search results
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post...
Benzinga· 7 days agoToday AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth ...
...Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal...
FOX 4 Kansas City· 5 days agoUnder the terms of the agreement, Nona Biosciences shall receive US$19 million upon completion...
AstraZeneca aims to deliver $80 billion in total revenue by 2030
KFGO· 7 days ago(Reuters) -AstraZeneca said on Tuesday it expects to deliver $80 billion in total revenue by 2030,...
AstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'
Investopedia· 7 days agoAstraZeneca's (AZN) American depositary receipts (ADRs) rose over 2% to a record high Tuesday after...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 6 days agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
AstraZeneca to establish $1.5bn ADC production site in Singapore
Pharmaceutical Technology via Yahoo Finance· 7 days agoAstraZeneca is set to invest $1.5bn in a new manufacturing facility in Singapore dedicated to...
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks· 7 days agoFree Report) announced its long-term plan to generate $80 billion in total revenues by 2030, which is significantly higher than $43.8 million generated in 2023. By 2030, AstraZeneca ...
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks via Yahoo Finance· 6 days agoAstraZeneca AZN announced its long-term plan to generate $80 billion in total revenues by 2030,...
SixPeaks, a new obesity biotech, starts up with an option to sell to AstraZeneca
BioPharma Dive via Yahoo Finance· 5 days agoA new obesity drug developer from investment firm Versant Ventures is starting up with a deal to...
AstraZeneca shares rise as pharma group unveils 2030 revenue target By Investing.com
Investing.com· 6 days agoU.K.-listed shares in AstraZeneca (LON:AZN) rose in morning trading on Tuesday after the...